Bleeding-related admissions in patients with atrial fibrillation receiving antithrombotic therapy: results from the Tasmanian Atrial Fibrillation (TAF) study
- 22 September 2017
- journal article
- pharmacoepidemiology and-prescription
- Published by Springer Science and Business Media LLC in European Journal of Clinical Pharmacology
- Vol. 73 (12), 1681-1689
- https://doi.org/10.1007/s00228-017-2337-9
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Uptake of novel oral anticoagulants in AustraliaThe Medical Journal of Australia, 2016
- Suboptimal Use of Oral Anticoagulants in Atrial Fibrillation: Has the Introduction of Direct Oral Anticoagulants Improved Prescribing Practices?American Journal of Cardiovascular Drugs, 2016
- Time trends in intracranial bleeding associated with direct oral anticoagulants: a 5-year cohort studyCMAJ Open, 2015
- 50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort studyThe Lancet, 2015
- Clinical outcomes and management associated with major bleeding in patients with atrial fibrillation treated with apixaban or warfarin: insights from the ARISTOTLE trialEuropean Heart Journal, 2014
- Bleeding Events Among New Starters and Switchers to Dabigatran Compared with Warfarin in Atrial FibrillationThe American Journal of Medicine, 2014
- Rates of hemorrhage during warfarin therapy for atrial fibrillationCMAJ : Canadian Medical Association Journal, 2012
- Risks of thromboembolism and bleeding with thromboprophylaxis in patients with atrial fibrillation: A net clinical benefit analysis using a ‘real world’ nationwide cohort studyThrombosis and Haemostasis, 2011
- Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT)The Lancet, 1996
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987